Kopran Q3 Results
- BSE: 524280
- NSE: KOPRAN
- ISIN: INE082A01010
- Sector: Biotechnology & Drugs
BSE
256.05
-20.40 (-7.38%)
-20.40 (-7.38%)Volume44.72 K
Updated: Thu 8 Oct, 2026 | 15:29:54
NSE
256-20.50 (-7.41%)
-20.50 (-7.41%)Volume6.26 L
Updated: Thu 8 Oct, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Kopran Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 178.46 | 140.68 | 49.68% | 138.60 | 18.66% |
| Depreciation/ Amortization | 4.42 | 3.85 | 3.14% | 3.27 | 10.49% |
| Operating Income | 15.82 | 10.88 | 0.00% | 20.32 | -0.15% |
| Net Income | 9.34 | 7.38 | 0.00% | 15.79 | -10.15% |
| Other Operating Expenses Total | 26.42 | 24.64 | 19.14% | 21.97 | 4.43% |
| Net Income Before Taxes | 10.74 | 9.64 | 0.00% | 20.51 | -22.47% |
| Total Revenue | 194.28 | 151.56 | 64.77% | 158.92 | 16.87% |
| Selling/ General/ Admin Expenses Total | 16.57 | 14.53 | -1.13% | 13.74 | 7.60% |
| Diluted Normalized EPS | 1.93 | 1.53 | 0.00% | 3.27 | -10.23% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.